Cargando…

Results from Expanded Access Programs: A Review of Academic Literature

BACKGROUND: Although expanded access is an increasingly used pathway for patients to access investigational medicine, little is known on the magnitude and content of published scientific research collected via expanded access. METHODS: We performed a review of all peer-reviewed expanded access publi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polak, Tobias B., Cucchi, David G. J., Schelhaas, Jasmin, Ahmed, Syed S., Khoshnaw, Naima, van Rosmalen, Joost, Uyl-de Groot, Carin A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193319/ https://www.ncbi.nlm.nih.gov/pubmed/37199856 http://dx.doi.org/10.1007/s40265-023-01879-4

Ejemplares similares

Real-world data from expanded access programmes in health technology assessments: a review of NICE technology appraisals
por: Polak, Tobias B, et al.
Publicado: (2022)

Generating Evidence from Expanded Access Use of Rare Disease Medicines: Challenges and Recommendations
por: Polak, Tobias B., et al.
Publicado: (2022)

Expanded Access as a source of real‐world data: An overview of FDA and EMA approvals
por: Polak, Tobias B., et al.
Publicado: (2020)

Medical Resource Use and Medical Costs for Radiotherapy-Related Adverse Effects: A Systematic Review
por: Chen, Yi Hsuan, et al.
Publicado: (2022)

Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe
por: Uyl-de Groot, Carin A., et al.
Publicado: (2020)

Retention of doctors in emergency medicine: a scoping review of the academic literature
por: Darbyshire, Daniel, et al.
Publicado: (2021)

Efficacy and Safety Results of the Afatinib Expanded Access Program
por: Kim, Edward S., et al.
Publicado: (2017)

Navigating the Expanded Access Pathway to Investigational Drugs as an Academic Oncologist
por: Fernandez Lynch, Holly, et al.
Publicado: (2023)

Perspectives of Academic Oncologists About Offering Expanded Access to Investigational Drugs
por: Gould, Patrick, et al.
Publicado: (2022)

Academic entrepreneurial engagement for frugal innovation in higher education institutions: a systematic literature review
por: Toyin Ojo, Oluwayomi, et al.
Publicado: (2023)

Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer
por: Zaim, Remziye, et al.
Publicado: (2022)

Building capacity in dissemination and implementation science: a systematic review of the academic literature on teaching and training initiatives
por: Davis, Rachel, et al.
Publicado: (2020)

A Systematic Review of the Incremental Costs of Implementing a New Vaccine in the Expanded Program of Immunization in Sub-Saharan Africa
por: Brew, Joe, et al.
Publicado: (2019)

Learning from complaints in healthcare: a realist review of academic literature, policy evidence and front-line insights
por: van Dael, Jackie, et al.
Publicado: (2020)

Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis
por: Polak, Tobias B., et al.
Publicado: (2022)

Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy
por: Ansaripour, Amir, et al.
Publicado: (2017)

Economic evaluations of big data analytics for clinical decision-making: a scoping review
por: Bakker, Lytske, et al.
Publicado: (2020)

How can we discover the most valuable types of big data and artificial intelligence-based solutions? A methodology for the efficient development of the underlying analytics that improve care
por: Bakker, Lytske, et al.
Publicado: (2021)

Cost-effectiveness of first line nivolumab-ipilimumab combination therapy for advanced non-small cell lung cancer: A systematic review and methodological quality assessment
por: Zaim, Remziye, et al.
Publicado: (2023)

Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer
por: Zaim, Remziye, et al.
Publicado: (2023)

Access and use of immunoglobulins in secondary supportive cancer care: A systematic literature review
por: Counihan, Muireann, et al.
Publicado: (2023)

A Qualitative Systematic Review of Access to Substance Use Disorder Care in the United States Criminal Justice System
por: Barenie, Rachel E., et al.
Publicado: (2022)

National landscape assessment of academic medical center support for expanded access to investigational products
por: Gravelin, Misty, et al.
Publicado: (2022)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
por: van der Gronde, Toon, et al.
Publicado: (2017)

Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands
por: Xander, Nicolas S. H., et al.
Publicado: (2023)

Assessing the impact of caregiving on informal caregivers of adults with a mental disorder in OECD countries: A systematic literature review of concepts and their respective questionnaires
por: Bremmers, Leonarda G. M., et al.
Publicado: (2022)

Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature
por: Patikorn, Chanthawat, et al.
Publicado: (2021)

How is the Topic of Intersex Athletes in Elite Sports Positioned in Academic Literature Between January 2000 and July 2022? A Systematic Review
por: Jensen, Marisa, et al.
Publicado: (2022)

The Impact of Patient Support Programs in Europe: A Systematic Literature Review
por: Sacristán, José Antonio, et al.
Publicado: (2022)

Ureteral Access Sheaths and Its Use in the Future: A Comprehensive Update Based on a Literature Review
por: De Coninck, Vincent, et al.
Publicado: (2022)

Expanding etiology of progressive familial intrahepatic cholestasis
por: Henkel, Sarah AF, et al.
Publicado: (2019)

Onderdiagnostiek bij kanker door de COVID-19-crisis naar diagnose, leeftijd en provincie: Een cruciale rol voor eerstelijnszorgverleners
por: Uyl-de Groot, Carin A., et al.
Publicado: (2020)

Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands
por: Luyendijk, Marianne, et al.
Publicado: (2023)

Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors
por: Klopfenstein, Mitchell, et al.
Publicado: (2015)

Characterizing expanded access and compassionate use programs for experimental drugs
por: Miller, Jennifer E., et al.
Publicado: (2017)

Taking AIM at serious illness: implementing an access to investigational medicines expanded access program
por: Joly, Meghan Morrison, et al.
Publicado: (2023)

Urban poverty and nutrition challenges associated with accessibility to a healthy diet: a global systematic literature review
por: Vilar-Compte, Mireya, et al.
Publicado: (2021)

Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis
por: Fleischmann-Struzek, C., et al.
Publicado: (2020)

Academic Procrastination in Children and Adolescents: A Scoping Review
por: González-Brignardello, Marcela Paz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p29vl5je27l2mfcrrtp22j8a20